Clin Mol Hepatol.
2013 Sep;19(3):210-215. 10.3350/cmh.2013.19.3.210.
Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
- Affiliations
-
- 1Department of Life Sciences, Korea University, Seoul, Korea. koohoi@korea.ac.kr
- KMID: 1705200
- DOI: http://doi.org/10.3350/cmh.2013.19.3.210
Abstract
- Liver plays a central role in the biogenesis of major metabolites including glucose, fatty acids, and cholesterol. Increased incidence of obesity in the modern society promotes insulin resistance in the peripheral tissues in humans, and could cause severe metabolic disorders by inducing accumulation of lipid in the liver, resulting in the progression of non-alcoholic fatty liver disease (NAFLD). NAFLD, which is characterized by increased fat depots in the liver, could precede more severe diseases such as non-alcoholic steatohepatitis (NASH), cirrhosis, and in some cases hepatocellular carcinoma. Accumulation of lipid in the liver can be traced by increased uptake of free fatty acids into the liver, impaired fatty acid beta oxidation, or the increased incidence of de novo lipogenesis. In this review, I would like to focus on the roles of individual pathways that contribute to the hepatic steatosis as a precursor for the NAFLD.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
- Waiting for the changes after the adoption of steatotic liver disease
- Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
- Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease
- Management of Patients with Nonalcoholic Fatty Liver Disease with Lifestyle Modification
